A dynamic in-vitro model of the intestinal epithelium for the investigation of P-glycoprotein activity

Multidrug resistance is still an obstacle for chemotherapeutic treatments. One of the proteins involved in this phenomenon is the P-glycoprotein, P-gp, which is known to be responsible for the efflux of therapeutic substances from the cell cytoplasm. To date, the identification of a drug that can efficiently inhibit P-gp activity remains a challenge, nevertheless some studies have identified natural compounds suitable for that purpose. Amongst them, curcumin has shown an inhibitory effect on the protein in in vitro studies using Caco-2 cells.To understand if physiological flow can modulate membrane protein activity, we studied the uptake of a P-gp substrate under static and dynamic conditions. Caco-2 cells were cultured in bioreactors and in Transwells and the basolateral transport of Rhodamine-123 assessed in the two systems as a function of P-gp activity. Experiments were performed with and without pre-treatment of the cells with an extract of curcumin or an arylmethyloxy-phenyl derivative to evaluate the inhibitory effect of the natural substance with respect to a synthetic compound.The results indicated that the P-gp activity of the cells cultured in the bioreactors was intrinsically lower, and that the effect of both natural and synthetic inhibitors was up modulated by the presence of flow. Our study underlies the fact that the use of more sophisticated and physiologically relevant in vitro models can bring new insights on the therapeutic effects of natural substances such as curcumin.

[1]  J. Costa,et al.  Real-time cellular impedance monitoring and imaging of biological barriers in a dual-flow membrane bioreactor. , 2019, Biosensors & bioelectronics.

[2]  X. Illa,et al.  Engineering and monitoring cellular barrier models , 2018, Journal of Biological Engineering.

[3]  H. Hsieh,et al.  Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer , 2017, Scientific Reports.

[4]  B. Aggarwal,et al.  Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. , 2017, Clinical science.

[5]  Caroline C. O'Brien,et al.  Pulsatility and high shear stress deteriorate barrier phenotype in brain microvascular endothelium , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Daniele Mazzei,et al.  Environmental Control in Flow Bioreactors , 2017 .

[7]  Jong-ryul Choi,et al.  Localized Down-regulation of P-glycoprotein by Focused Ultrasound and Microbubbles induced Blood-Brain Barrier Disruption in Rat Brain , 2016, Scientific Reports.

[8]  H. Walles,et al.  Development of an Advanced Primary Human In Vitro Model of the Small Intestine. , 2016, Tissue engineering. Part C, Methods.

[9]  Mandy B. Esch,et al.  TEER Measurement Techniques for In Vitro Barrier Model Systems , 2015, Journal of laboratory automation.

[10]  C. Cho,et al.  Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[11]  Claudio Domenici,et al.  A novel dual‐flow bioreactor simulates increased fluorescein permeability in epithelial tissue barriers , 2014, Biotechnology journal.

[12]  Arti Ahluwalia,et al.  Design Criteria for Generating Physiologically Relevant In Vitro Models in Bioreactors , 2014 .

[13]  A. Lamprecht,et al.  A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  R. Perrone,et al.  SAR study on arylmethyloxyphenyl scaffold: looking for a P-gp nanomolar affinity. , 2014, European journal of medicinal chemistry.

[15]  S. Andreadis,et al.  Differential and synergistic effects of mechanical stimulation and growth factor presentation on vascular wall function. , 2013, Biomaterials.

[16]  J. Kanwar,et al.  Curcumin Regulates Colon Cancer by Inhibiting P-Glycoprotein in In-situ Cancerous Colon Perfusion Rat Model , 2013, Journal of cancer science & therapy.

[17]  Lei Li,et al.  Effect of curcumin on human colon cancer multidrug resistance in vitro and in vivo , 2013, Clinics.

[18]  L. Benet,et al.  Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements , 2013, The AAPS Journal.

[19]  E. Kennelly,et al.  The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. , 2012, Journal of medicinal food.

[20]  S. Cisternino,et al.  Heterogeneity in the Rat Brain Vasculature Revealed by Quantitative Confocal Analysis of Endothelial Barrier Antigen and P-Glycoprotein Expression , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Katja Schenke-Layland,et al.  The physiological performance of a three-dimensional model that mimics the microenvironment of the small intestine. , 2011, Biomaterials.

[22]  S. Ki,et al.  Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin. , 2011, Biopharmaceutics & drug disposition.

[23]  N. Piyapolrungroj,et al.  Effects of Curcuma spp. on P-glycoprotein function. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[24]  Jean-Pierre Gillet,et al.  Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.

[25]  H. Lage An overview of cancer multidrug resistance: a still unsolved problem , 2008, Cellular and Molecular Life Sciences.

[26]  J. Azuma,et al.  Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. , 2008, International journal of pharmaceutics.

[27]  F. Berardi,et al.  Synthesis and biological evaluation of (hetero)arylmethyloxy- and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents. , 2008, Journal of medicinal chemistry.

[28]  A. Paradiso,et al.  Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives. , 2008, Bioorganic & medicinal chemistry.

[29]  Olivier Fardel,et al.  Analysis of drug transporter expression in human intestinal Caco‐2 cells by real‐time PCR , 2007, Fundamental & clinical pharmacology.

[30]  F. Berardi,et al.  Arylmethyloxyphenyl derivatives: small molecules displaying P-glycoprotein inhibition. , 2006, Journal of medicinal chemistry.

[31]  A. Andriulli,et al.  Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. , 2006, World journal of gastroenterology.

[32]  Brian P Helmke,et al.  Mechanisms of mechanotransduction. , 2006, Developmental cell.

[33]  S. Kitagawa,et al.  Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. , 2005, Biochemical and biophysical research communications.

[34]  Andreas Janshoff,et al.  Automated multi-well device to measure transepithelial electrical resistances under physiological conditions. , 2004, BioTechniques.

[35]  R. Borchardt,et al.  Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. , 2004, Journal of pharmaceutical sciences.

[36]  R. Conradi,et al.  Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa , 1990, Pharmaceutical Research.

[37]  J. Satsangi,et al.  Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? , 2003, Gut.

[38]  H. Coley,et al.  Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. , 2003, Cancer control : journal of the Moffitt Cancer Center.

[39]  J. P. Fawcett,et al.  The involvement of P-glycoprotein in berberine absorption. , 2002, Pharmacology & toxicology.

[40]  L. Benet,et al.  The drug efflux-metabolism alliance: biochemical aspects. , 2001, Advanced drug delivery reviews.

[41]  M. Pirmohamed,et al.  Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. , 2001, Clinical Cancer Research.

[42]  M. Balda,et al.  Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical- basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein , 1996, The Journal of cell biology.

[43]  P. Twentyman,et al.  A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. , 1994, European journal of cancer.

[44]  Thomas J. Raub,et al.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.